Cases 51 - 60 of 105
Janssen Biotech Inc. et al v. Amneal Pharmaceuticals LLC et al
as 1:2015cv00679
Plaintiff:
Janssen Biotech Inc. , Janssen Oncology Inc. and Janssen Research & Development LLC
Defendant:
Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC, Par Pharmaceutical Inc. and others
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical Inc. et al v. Breckenridge Pharmaceutical Inc. et al
as 1:2015cv00486
Plaintiff:
Par Pharmaceutical Inc. and Alkermes Pharma Ireland Limited
Defendant:
Breckenridge Pharmaceutical Inc., TWi Pharmaceuticals Inc. and TWi Pharmaceuticals USA Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Par Pharmaceutical, Inc.
as 1:2015cv00475
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Par Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Helsinn Healthcare S.A. et al v. Par Pharmaceutical Companies Inc. et al
as 1:2015cv00265
Plaintiff:
Helsinn Healthcare S.A. and Roche Palo Alto LLC
Defendant:
Par Pharmaceutical Companies Inc. and Par Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Ferring Pharmaceuticals Inc. et al v. Par Pharmaceutical Inc.
as 1:2015cv00173
Plaintiff:
Ferring Pharmaceuticals Inc. and Ferring International Center SA
Defendant:
Par Pharmaceutical Inc.
Counter_claimant:
Par Pharmaceutical Inc.
Counter_defendant:
Ferring International Center SA and Ferring Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Cosmo Technologies Limited et al v. Par Pharmaceutical Inc.
as 1:2015cv00116
Plaintiff:
Cosmo Technologies Limited and Santarus Inc.
Defendant:
Par Pharmaceutical Inc.
Counter_claimant:
Par Pharmaceutical Inc.
Counter_defendant:
Cosmo Technologies Limited and Santarus Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Par Pharmaceutical Inc.
as 1:2015cv00078
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Par Pharmaceutical Inc.
Counter_claimant:
Par Pharmaceutical Inc.
Counter_defendant:
Novartis AG and Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Tris Pharma Inc. v. Par Pharmaceutical Inc. et al
as 1:2015cv00068
Plaintiff:
Tris Pharma Inc.
Defendant:
Par Pharmaceutical Inc. and Par Pharmaceutical Companies Inc.
Counter_claimant:
Par Pharmaceutical Inc. and Par Pharmaceutical Companies Inc.
Counter_defendant:
Tris Pharma Inc.
Cause Of Action: 35 U.S.C. § 271
Reckitt Benckiser Pharmaceuticals Inc. et al v. Par Pharmaceutical Inc. et al
as 1:2014cv01573
Plaintiff:
Reckitt Benckiser Pharmaceuticals Inc. and MonoSol Rx LLC
Defendant:
Par Pharmaceutical Inc. and IntelGenX Technologies Corp.
Counter_claimant:
IntelGenX Technologies Corp. and Par Pharmaceutical Inc.
Counter_defendant:
MonoSol Rx LLC and Reckitt Benckiser Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation et al v. Par Pharmaceutical Inc.
as 1:2014cv01494
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Par Pharmaceutical Inc.
Counter_claimant:
Par Pharmaceutical Inc.
Counter_defendant:
Novartis AG and Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
